Multiple roles of the candidate oncogene ZNF217 in ovarian epithelial neoplastic progression

International Journal of Cancer

Volumn 120, Issue 9, 2007, Pages 1863-1873

  Li, Peixiang ^a   Maines Bandiera, Sarah ^a   Kuo, Wen Lin ^b   Guan, Yinghui ^b   Sun, Yu ^a   Hills, Mark ^c   Huang, Guiqing ^b   Collins, Collin C ^b   Leung, Peter C K ^a   Gray, Joe W ^b,d   Auersperg, Nelly ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Immortalization; Oncogene; Ovarian cancer; ZNF217

Indexed keywords

ANNEXIN; ANNEXIN A10; DESMOCOLLIN; DESMOCOLLIN 3; EPIDERMAL GROWTH FACTOR; NERVE CELL ADHESION MOLECULE; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEIN; PROTEIN EEF1A2; PROTEIN P53; PROTEIN SMARA3; RETINOBLASTOMA PROTEIN; SCLEROPROTEIN; SMALL INTERFERING RNA; STAT1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZNF217; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADENOVIRUS; AMPLICON; ARTICLE; CANCER GROWTH; CELL ADHESION; CELL AGING; CELL ANCHORAGE; CELL GROWTH; CELL LINE; CHROMOSOME 18; CHROMOSOME 20Q; CHROMOSOME 3Q; CHROMOSOME 4Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; ONCOGENE; ONCOGENE ZNF217; OVARY CANCER; PRIORITY JOURNAL; RETROVIRUS INFECTION; SIMIAN VIRUS 40; VIRUS INFECTION;

ADENOVIRIDAE; CELLS, CULTURED; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; HYDROCORTISONE; NUCLEIC ACID HYBRIDIZATION; OVARIAN NEOPLASMS; PHENOTYPE; TRANS-ACTIVATORS;

EID: 33947274769     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22300     Document Type: Article

References (42)

1. Collins C, Volik S, Kowbel D, Ginzinger D, Yistra B, Cloutier T, Hawkins T, Predki P, Martin C, Wernick M, Kuo W-L, Alberts A, et al. Comprehensive genome sequence analysis of a breast cancer amplicon. Genome Res 2001;11:1034-42.
2. Collins C, Rommens JM, Kowbel D, Godfrey T, Tanner M, Hwang SI, Polikoff D, Nonet G, Cochran J, Myambo K, Jay KE, Froula J, et al. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci USA 1998;95:8703-8.
3. Bar-Shira A, Pinthus JH, Rozovsky U, Goldstein M, Sellers WR, Yaron Y, Eshar Z, Orr-Urtreger A. Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res 2002;62:6803-7.
4. Freier K, Joos S, Hechtenmacher C, Devens F, Benner A, Bosch FX, Lichter P, Hofele C. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 2003;63:1179-82.
5. Weiss MM, Snijders AM, Kuipers EJ, Ylstra B, Pinkel D, Meuwissen SO, van Diest PJ, Albertson DG, Meijer GA. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization. J Pathol 2003;200:320-6.
6. Rooney PH, Boonsong A, McFadyen MC, McLeod HL, Cassidy J, Curran S, Murray GI. The candidate oncogene ZNF217 is frequently amplified in colon cancer. J Pathol 2005;204:282-8.
7. Yang SH, Seo MY, Jeong HJ, Jeung HC, Shin J, Kim SC, Noh SH, Chung HC, Rha SY. Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients. Clin Cancer Res 2005;11:612-20.
8. Hidaka S, Yasutake T, Takeshita H, Kondo M, Tsuji T, Nanashima A, Sawai T, Yamaguchi H, Nakagoe T, Ayabe H, Tagawa Y. Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis. Clin Cancer Res 2000;6:2712-17.
9. Toncheva D, Zaharieva B. Coexistence of copy number changes of different genes (INK4A, erbB-1, erbB-2, CMYC, CCND1 and ZNF217) in urothelial tumors. Tumour Biol 2005;26:88-93.
10. Shimada M, Imura J, Kozaki T, Fujimori T, Asakawa S, Shimizu N, Kawaguchi R. Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization. Oncol Rep 2005;13:633-41.
11. Tanner MM, Grenman S, Koul A, Johannsson O, Meltzer P, Pejovic T, Borg A, Isola JJ. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 2003;6:1833-9.
12. Watanabe T, Imoto I, Katahira T, Hirasawa A, Ishiwata I, Emi M, Takayama M, Sato A. Inazawa J. Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers. Jpn J Cancer Res 2002;93:1114-22.
13. Ginzinger-DG, Godfrey TE, Nigro J, Moore DH, II, Suzuki S, Pallavicini MG, Gray JW, Jensen RH. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res 2000;60:5405-9.
14. Peiro G, Diebold J, Lohrs U. CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression. Am J Clin Pathol 2002;118:922-9.
15. Savelieva E, Belair CD, Newton MA, DeVries S, Gray JW, Waldman F, Reznikoff CA. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells. Oncogene 1997;14: 551-60.
16. Cuthill S, Agarwal P, Sarkar S, Savelieva E, Reznikoff CA. Dominant genetic alterations in immortalization: role for 20q gain. Genes Chromosomes Cancer 1999;26:304-11.
17. Nonet GH, Stampfer MR, Chin K, Gray JW, Collins CC, Yaswen P. The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. Cancer Res 2001;61:1250-4.
18. Huang G, Krig S, Kowbel D, Xu H, Hyun B, Volik S, Feuerstein B, Mills GB, Stokoe D, Yaswen P, Collins C. ZNF217 suppresses cell death associated with chemotherapy and telomere dysfunction. Hum Mol Genet 2005;14:3219-25.
19. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001;22:255-88.
20. Maines-Bandiera SL, Kruk PA, Auersperg N. Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix. Am J Obstet Gynecol 1992;167:729-35.
21. Snijders AM, Nowak N, Segraves R, Blackwood S, Brown N, Conroy J, Hamilton G, HIndle AK, Huey B, Kimura K, Law S, Myambo K, et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 2001;29:263-4.
22. Snijders AM, Fridlyand J, Mans DA, Segraves R, Jain AN, Pinkel D, Albertson DG. Shaping of tumor and drug-resistant genomes by instability and selection. Oncogene 2003;22:4370-9.
23. Jain AN, Tokuyasu TA, Snijders AM, Segraves R, Albertson DG. Pinkel D. Fully automatic quantification of microarray image data. Genome Res 2002;12:325-32.
24. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Bioinformatics 2003;4:249-64.
25. Baird DM, Rowson J, Wynford-Thomas D, Kipling D. Extensive allelic variation and ultrashort telomeres in senescent human cells. Nat Genet 2003;33:203-7.
26. Maida Y, Kyo S, Kanaya T, Wang Z, Yatabe N, Tanaka M, Nakamura M, Ohmichi M, Gotoh N, Murakami S, Inoue M. Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway. Oncogene 2002;21:4071-9.
27. Salamanca CM, Maines-Bandiera SL, Leung PC, Hu YL, Auersperg N. Effects of epidermal growth factor/hydrocortisone on the growth and differentiation of human ovarian surface epithelium. J Soc Gynecol Invest 2004;11:241-51.
28. Liu S-H, Lin C-Y, Peng S-Y, Jeng Y-M, Pan H-W, Lai P-L, Liu C-L, Hsu H-C. Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation. Am J Pathol 2002;160:1831-7.
29. Klus GT, Rokaeus N, Bittner ML, Chen Y, Korz DM, Sukumar S, Schick A, Szallasi Z. Down-regulation of the desmosomal cadherin desmocollin 3 in human breast cancer. Int J Oncol 2001;19:169-74.
30. Shimizu T, Sato K, Suzuki T, Tachibana K, Takeda K. Induction of plasminogen activator inhibitor-2 is associated with suppression of invasive activity in TPA, mediated differentiation of human prostate cancer cells. Biochem Biophys Res Commun 2003;309:267-71.
31. Hagihara A, Miyamoto K, Furuta J, Hiraoka N, Wakazono K, Seki S, Fukushima S, Tsao MS, Sugimura T, Ushijima T. Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers. Oncogene 2004;23:8705-10.
32. Dimri GP. What has senescence got to do with cancer?. Cancer Cell. 2005;7:505-12.
33. Flesken-Nitikin A, Choi KC, Eng JP, Shmidt EN, Nikitin AY. Induction of carcinogenesis by concurrent inactivation of p53 and Rb 1 in the mouse ovarian surface epithelium. Cancer Res 2003;63:3459-63.
34. Liu J, Yang G, Thompson-Lanza JA, Classman A, Hayes K, Patterson A, Marquez RT, Auersperg N, Yu Y, Hahn WC, Mills GB, Bast RC, Jr. A genetically defined model for human ovarian cancer. Cancer Res 2004;64:1655-63.
35. Davies BR, Steele IA, Edmondson RJ, Zwolinski SA, Saretzki G, von Zglinicki T, O'Hare MJ. Immortalisation of human ovarian surface epithelium with telomerase and temperature-sensitive SV40 large T antigen. Exp Cell Res 2003;288:390-402.
36. McClellan M, Kievit P, Auersperg N, Rodland K. Regulation of proliferation and apoptosis by epidermal growth factor and protein kinase C in human ovarian surface epithelial cells. Exp Cell Res 1999;246: 471-9.
37. Awwad RA, Sergina N, Yang H, Ziober B, Willson JK, Zborowska E, Humphrey LE, Fan R, Ko TC, Brattain MG, Howell GM. The role of transforming growth factor alpha in determining growth factor independence. Cancer Res 2003;63:4731-8.
38. Li S, Rosenberg JE, Donjacour AA, Botchkina AL, Hom YK, Cunha GR, Blackburn EH. Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. Cancer Res 2004; 64:4833-40.
39. Gray JW, Suzuki S, Kuo WL, Polikoff D, Deavers M, Smith-McCune K, Berchuck A, Pinkel D, Albertson D, Mills GB. Specific keynote: genome copy number abnormalities in ovarian cancer. Gynecol Oncol 2003;88:S16-S21.
40. Anand N, Murthy S, Amann G, Wernick M, Porter LA, Cukier IH, Coll C, Gray JW, Diebold J, Demetrick DJ, Lee JM. Gene encoding protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat Genet 2002;31:301-5.
41. Zahir N, Lakins JN, Russell A, Ming W-Y, Chatterjee C, Rozenberg GI, Marinkovich MP, Weaver VM. Autocrine laminin-5 ligates alpha6beta4 integrin and activates RAC and NFkappaB to mediate anchorage-independent survival of mammary tumors. J Cell Biol 2003;163: 1397-407.
42. Soubry A, van Hegel J, Parthoens E, Colpaert C, Van Marck E, Waltregny D, Reynolds AB, van Roy F. Expression and nuclear location of the transcriptional repressor Kaiso is regulated by the tumor microenvironment. Cancer Res 2005;65:2224-33.